Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Wakako Tajiri"'
Autor:
Yumiko Koi, Wakako Tajiri, Junji Kawasaki, Sayuri Akiyoshi, Hideki Ijichi, Yoshiaki Nakamura, Chinami Koga, Yutaka Koga, Kenichi Taguchi, Eriko Tokunaga
Publikováno v:
Thoracic Cancer, Vol 15, Iss 28, Pp 2073-2076 (2024)
Abstract We present a unique case of metastatic metaplastic breast carcinoma responding dramatically to immunochemotherapy. A 46‐year‐old Japanese woman with primary metaplastic carcinoma of the breast, which was immunohistochemically confirmed t
Externí odkaz:
https://doaj.org/article/6c0fca18edee42b7b7a6d73f6577b101
Autor:
Sumire Koh, Yumiko Koi, Wakako Tajiri, Junji Kawasaki, Sayuri Akiyoshi, Yoshiaki Nakamura, Chinami Koga, Tatsuro Okamoto, Kenichi Taguchi, Eriko Tokunaga
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-6 (2024)
Abstract Background Distant metastases from lung cancer are commonly found in the brain, bone, and liver. Metastases to the breast from non-mammary malignancies are extremely rare, and their clinical presentations remain unclear. Case presentation We
Externí odkaz:
https://doaj.org/article/ca0e90c3348946f89982d333bf907dcf
Autor:
Wakako Tajiri, Sumire Koh, Yoshiaki Nakamura, Junji Kawasaki, Yumiko Koi, Chinami Koga, Hideki Ijichi, Eriko Tokunaga
Publikováno v:
Cancer Research. 83:P3-05
Background: Breast cancer incidence is constantly increasing in Japan. The age-specific incidence rates (ASIRs) of breast cancer shows two peaks, at ages 45-49 and 60-64, in Japan. Therefore, the incidence rate of breast cancer in Japanese premenopau
Autor:
Marie, Hara, Tomoaki, Eto, Hideki, Ijichi, Yoshiaki, Nakamura, Chinami, Koga, Wakako, Tajiri, Masahiro, Okamoto, Eriko, Tokunaga, Nobuhiro, Misumi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(12)
Docetaxel(DTX)is a key drug for breast cancer treatment; however, its formulation contains alcohol, which can cause several problems. We have been preparing original DTX without using its accompanying alcohol-solubilizing solution since 2013 and swit
Autor:
Kenichi Taguchi, Hideki Ijichi, Wakako Tajiri, Chinami Koga, Masahiro Okamoto, Shinji Ohno, Takanobu Masuda, Yumiko Koi, Yoshiaki Nakamura, Eriko Tokunaga
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background Several studies have recently reported that the relationships between serum vitamin D and the prognosis or the pathological response to neoadjuvant chemotherapy (NAC) in breast cancer. However, there are no data regarding the clinical impa
Autor:
Masahiro Okamoto, Wakako Tajiri, Hideki Ijichi, Yoshiaki Nakamura, Katsumi Takizawa, Takanobu Masuda, Eriko Tokunaga, Chinami Koga, Hiroki Ueo, Yumiko Koi, Kenichi Taguchi
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background Clinical Treatment Score post-5 years (CTS5) is a promising prognostic tool to evaluate late distant recurrence (DR) risk for breast cancer after 5-year adjuvant endocrine therapy. Patients and methods Among 560 postmenopausal women with p
Autor:
Chinami Koga, Kenichi Taguchi, Kimiko Baba, Sayuri Akiyoshi, Katsumi Takizawa, Aya Fujita, Yoshiaki Nakamura, Shinji Ohno, Mayumi Ishida, Wakako Tajiri, Hideki Ijichi, Takanobu Masuda, Eriko Tokunaga
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background Neoadjuvant chemotherapy (NAC) is the standard therapeutic strategy for triple-negative breast cancer (TNBC). TNBC patients with residual disease after NAC have a significantly worse survival than those with pathological complete response
Autor:
Wakako Tajiri, Takanobu Masuda, K Takizawa, Eriko Tokunaga, M Ishida, Junko Tanaka, Hideki Ijichi, Yoshiaki Nakamura, Kenichi Taguchi, Chinami Koga
Publikováno v:
Cancer Research. 78:P2-09
This abstract was not presented at the symposium.
Autor:
Hiroki Ueo, Masahiro Okamoto, Kennichi Taguchi, Yoshiaki Nakamura, Azusa Sugii, Chinami Koga, Wakako Tajiri, Eriko Tokunaga, Hideki Ijichi
Publikováno v:
Cancer Research. 80:P5-06
The Clinical Treatment Score post-5 years (CTS5) is a prognostic tool to estimate the residual risk of distant recurrence (DR) after 5 years of endocrine therapy in postmenopausal women with estrogen receptor (ER)-positive breast cancer. (J Clin Onco
Autor:
Kenichi Taguchi, Junko Tanaka, Wakako Tajiri, Masahiro Okamoto, Yoshiaki Nakamura, Takanobu Masuda, Eriko Tokunaga, Hideki Ijichi, Chinami Koga
Publikováno v:
Journal of Clinical Oncology. 37:e12088-e12088
e12088 Background: Neoadjuvant chemotherapy (NAC) is one of the standard therapeutic strategies for operable early breast cancer (BC). A relationship between chemotherapy response and the prognosis has been suggested, especially in HER2+ or triple ne